Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy by the determination of the Time To
Progression (TTP) in patients with resectable GBM or non surgical GBM with a size less than 5
cm treated with the combination of ZARNESTRA plus Radiation therapy.